Will AMAG Pharmaceuticals, Inc. (AMAG) Short Squeeze Soon? The Stock Formed a Bearish Double Bottom

February 15, 2018 - By simple simple

Investors sentiment increased to 1.44 in Q3 2017. Its up 0.35, from 1.09 in 2017Q2. It increased, as 21 investors sold AMAG Pharmaceuticals, Inc. shares while 43 reduced holdings. 35 funds opened positions while 57 raised stakes. 39.98 million shares or 4.47% less from 41.85 million shares in 2017Q2 were reported.
Millennium Ltd Llc invested in 1.53 million shares or 0.04% of the stock. Bridgeway Capital Mngmt has invested 0.02% in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG). D E Shaw reported 1.19M shares or 0.03% of all its holdings. Deutsche Fincl Bank Ag has 109,306 shares for 0% of their portfolio. Css Ltd Liability Corp Il holds 0% or 4,500 shares in its portfolio. 4,012 were reported by Ameritas Investment Prtnrs Incorporated. Lsv Asset Management owns 1.48 million shares or 0.05% of their US portfolio. Barclays Public stated it has 5,532 shares. Cubist Systematic Strategies Ltd Liability invested 0.01% in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG). Public Sector Pension Inv Board holds 21,823 shares. Arizona State Retirement Systems reported 18,300 shares. Blackrock Incorporated reported 0% stake. Tci Wealth Advisors reported 49 shares. 21,072 were accumulated by Signalpoint Asset Management Limited Liability Co. Vanguard Grp stated it has 3.22 million shares.

Since August 29, 2017, it had 0 insider purchases, and 1 sale for $20,938 activity.

The chart of AMAG Pharmaceuticals, Inc. (AMAG) shows a double bottom with $16.86 target or 5.00 % below today’s $17.75 share price. The 9 months chart pattern indicates high risk for the $627.89M company. It was reported on Feb, 15 by Finviz.com. If the $16.86 price target is reached, the company will be worth $31.39M less. Double bottoms are rare but powerful chart patterns.

The stock increased 27.70% or $3.85 during the last trading session, reaching $17.75. About 9.83M shares traded or 1073.39% up from the average. AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) has risen 3.00% since February 15, 2017 and is uptrending. It has underperformed by 13.70% the S&P500.

AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Ratings Coverage

Among 14 analysts covering AMAG Pharmaceuticals (NASDAQ:AMAG), 4 have Buy rating, 1 Sell and 9 Hold. Therefore 29% are positive. AMAG Pharmaceuticals had 40 analyst reports since August 18, 2015 according to SRatingsIntel. Cantor Fitzgerald maintained AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) rating on Monday, July 24. Cantor Fitzgerald has “Hold” rating and $2300 target. The stock of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) earned “Buy” rating by Jefferies on Tuesday, June 6. The stock has “Strong-Buy” rating by Zacks on Wednesday, August 19. The rating was reinitiated by Deutsche Bank with “Hold” on Thursday, September 3. On Thursday, February 15 the stock rating was upgraded by Janney Capital to “Buy”. The rating was initiated by Raymond James on Tuesday, September 1 with “Outperform”. On Thursday, January 21 the stock rating was initiated by Barclays Capital with “Equal-Weight”. On Thursday, August 11 the stock rating was maintained by Jefferies with “Buy”. On Wednesday, August 16 the stock rating was maintained by Jefferies with “Buy”. The rating was initiated by Needham with “Buy” on Thursday, October 27.

More notable recent AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) news were published by: Nasdaq.com which released: “Commit To Purchase AMAG Pharmaceuticals At $12, Earn 43.9% Annualized Using …” on January 23, 2018, also Globenewswire.com with their article: “AMAG Pharmaceuticals Announces FDA Approval of Supplemental New Drug …” published on February 05, 2018, Nasdaq.com published: “Why AMAG Pharmaceuticals, Inc. and Antares Pharma, Inc. Are Soaring Today” on February 15, 2018. More interesting news about AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) were released by: Seekingalpha.com and their article: “AMAG Pharmaceuticals Could Be February’s Breakout Biopharma Stock” published on January 30, 2018 as well as Marketwatch.com‘s news article titled: “Antares Pharma, Amag Pharma shares soar premarket after FDA approves auto injector” with publication date: February 15, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.